Evidence map›Paper›PMID 26120517›Full record

ReviewAllergo journal international

Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance.

Markus Hahn, Alexander F Hagel, Simon Hirschmann, Caroline Bechthold, Peter Konturek, Markus Neurath, Martin Raithel

Open access · bronzeAbstract readReview
In one paragraph

Review in Allergo journal international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Markus HahnRegionalspital Emmental, Burgdorf, Switzerland.
Alexander F HagelDepartment of Medicine 1, Gastroenteroloy, Pneumology and Endocrinology, University Hospital Erlangen, Erlangen, Germany.
Simon HirschmannDepartment of Medicine 1, Gastroenteroloy, Pneumology and Endocrinology, University Hospital Erlangen, Erlangen, Germany.
Caroline BechtholdDepartment of Medicine 1, Gastroenteroloy, Pneumology and Endocrinology, University Hospital Erlangen, Erlangen, Germany.
Peter KonturekGastroenteroloy, Thüringen-Kliniken, Saalfeld, Germany.
Markus NeurathDepartment of Medicine 1, Gastroenteroloy, Pneumology and Endocrinology, University Hospital Erlangen, Erlangen, Germany.
Martin RaithelDepartment of Medicine 1, Gastroenteroloy, Pneumology and Endocrinology, University Hospital Erlangen, Erlangen, Germany ; Medizinische Klinik 1, Universität Erlangen-Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany.
Universitätsklinikum Erlangen · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DERegionalspital Emmental · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At an incidence of 1:500, celiac disease (formerly sprue) is an important differential diagnosis in patients with malabsorption, abdominal discomfort, diarrhea and food intolerances. Celiac disease can induce a broad spectrum of both gastrointestinal and extraintestinal symptoms, e.g. dermatitis herpetiformis (Duhring's disease). A variety of oligo- and asymptomatic courses (e.g. anemia, osteoporosis, depression) through to refractory collagenic celiac disease are seen. In HLA-DQ2 and -8 predisposed individuals, celiac disease is provoked by contact with wheat gliadin fractions through a predominantly Th1 immune response and an accompanying Th2 response, which can eventually lead to villous atrophy. Using appropriate serological tests (IgA antibodies against tissue-transglutaminase, endomysium and deamidated gliadin peptides) under sufficient gluten ingestion, the diagnosis can be made more reliably today than previously. The same IgG-based serological tests should be used in the case of IgA deficiency. Diagnosis can either be made in children and adolescents with anti-transglutaminase titers exceeding ten times the standard for two of the above-mentioned serological markers and HLA conformity or it is made by endoscopy and histological Marsh classification in adults and in cases of inconclusive serology. If clinically tolerated, gluten challenges are indicated in patients that already have reduced gluten intake, in borderline serological results, discordance between serological and histological results or in suspected food allergy. The diagnosis of celiac disease needs to be definitive and robust before establishing a gluten-free diet, since lifelong abstention from gluten (gliadin < 20 mg/kg foodstuffs), cereal products (wheat, rye, barley and spelt) as well as from preparations and beverages containing gluten, is necessary. With effective elimination of gluten, the prognosis regarding complete resolution of small bowel inflammation is good. Refractory courses are seen only in rare cases, accompanied by enteropathy-associated T-cell lymphoma.

Indexed as

Celiac diseasecereal intoleranceenteropathymalabsorptionsprue

Identifiers

PMID26120517
PMCPMC4479435
OpenAlexW2073440174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.